Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
5jyq2C4jSqDJvM4K